Gerald G. Schumann

Articles in Scholarly Journals [Incomplete List]

  1. Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression
    Oncogene, vol. 26, no. 29, Article ID 1210214, 7 pages, 2007
  2. APOBEC3 proteins: major players in intracellular defence against LINE-1-mediated retrotransposition
    Biochemical Society Transactions, vol. 35, no. 3, p. 637, 2007
  3. APOBEC3 Proteins Inhibit Human LINE-1 Retrotransposition
    Journal of Biological Chemistry, vol. 281, no. 31, pp. 22161–22172, 2006
  4. Inhibition of LINE-1 expression in the heart decreases ischemic damage by activation of Akt/PKB signaling
    Physiological Genomics, vol. 25, no. 2, pp. 314–324, 2006
  5. APE-type non-LTR retrotransposons: determinants involved in target site recognition
    Cytogenetic and Genome Research, vol. 110, no. 1-4, pp. 250–268, 2005
  6. Analysis of 5' junctions of human LINE-1 and Alu retrotransposons suggests an alternative model for 5'-end attachment requiring microhomology-mediated end-joining
    Genome Research, vol. 15, no. 6, pp. 780–789, 2005
  7. Cell Type-specific Expression of LINE-1 Open Reading Frames 1 and 2 in Fetal and Adult Human Tissues
    Journal of Biological Chemistry, vol. 279, no. 26, pp. 27753–27763, 2004
  8. Therapeutic Effect of a Gag-Nuclease Fusion Protein against Retroviral Infection In Vivo
    Journal of Virology, vol. 75, no. 15, pp. 7030–7041, 2001
  9. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription
    Nucleic Acids Research, vol. 29, no. 21, pp. 4493–4501, 2001
  10. Skipper, an LTR retrotransposon of Dictyostelium
    Nucleic Acids Research, vol. 26, no. 8, pp. 2008–2015, 1998
  11. Moloney murine leukemia virus protease expressed in bacteria is enzymatically active
    Archives of Virology, vol. 143, no. 2, pp. 381–388, 1998
  12. Retrotransposon R1Bm endonuclease cleaves the target sequence
    Proceedings of the National Academy of Sciences, vol. 95, no. 5, pp. 2083–2088, 1998